Alsoud, D
519  Ergebnisse:
Personensuche X
?
1

P441 Adalimumab versus ustekinumab as first-line biological..:

Moens, A ; Verstockt, B ; Alsoud, D...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i423-i424 , 2022
 
?
2

P576 Real-world effectiveness and safety of risankizumab in..:

Alsoud, D ; Franchimont, D ; D'Heygere, F...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i516-i517 , 2022
 
?
3

P442 Real-world endoscopic and histologic outcomes are link..:

Alsoud, D ; Compernolle, G ; Tops, S...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i424-i424 , 2022
 
?
4

P447 Positioning of ustekinumab affects its effectiveness, ..:

Alsoud, D ; Sabino, J ; Ferrante, M..
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i427-i428 , 2022
 
?
5

P257 The clinical decision support tool has low performance..:

Alsoud, D ; Sabino, J ; Ferrante, M..
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i298-i299 , 2022
 
?
6

P401 Tofacitinib tissue exposure correlates with endoscopic..:

Verstockt, B ; Alsoud, D ; van Oostrom, J...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i394-i395 , 2022
 
?
7

P062 Effects of exposure to steroids on the PredictSURE who..:

Alsoud, D ; Verstockt, S ; Sabino, J...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S168-S168 , 2021
 
?
8

P309 Are results from VARSITY applicable to real world? Ada..:

Moens, A ; Verstockt, B ; Alsoud, D...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S336-S337 , 2021
 
?
9

P465 One year endoscopic and histologic outcomes to tofacit..:

Verstockt, B ; Aden, K ; Alsoud, D...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S456-S457 , 2021
 
?
10

DOP08 Serum proteomics predict endoscopic remission in pati..:

Alsoud, D ; Sudhakar, P ; Sabino, J...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S046-S047 , 2021
 
?
15

Beyond Discrimination: A Call for Comprehensive Assessment ..:

Alsoud, Dahham ; Van Calster, Ben
Inflammatory Bowel Diseases.  30 (2024)  6 - p. 1050-1051 , 2024
 
1-15